References

Berthold F, Hero B (2000) Neuroblastoma: current drug therapy recommendations as part of the total treatment approach. Drugs 59:1261-1277 Bowman LC, Hancock ML, Santana VM et al. (1991) Impact of intensified therapy on clinical outcome in infants and children with neuroblastoma: the St. Jude Children's Research Hospital experience, 1962 to 1988. J Clin Oncol 9:1599-1608 Bowman LC, Castleberry RP, Cantor A et al. (1997) Genetic staging of unresectable or metastatic neuroblastoma in infants: a Pediatric Oncology Group Study. J Natl Cancer Inst 89:373-380

Castel V, Badal MD, Bezanilla JL et al. (1995) Treatment of stage III neuroblastoma with emphasis on intensive induction chemotherapy: a report from the Neuroblastoma Group of the Spanish Society of Pediatric Oncology. Med Pediatr Oncol 24:29-35

Castleberry RP, Kun LE, Shuster JJ et al. (1991) Radiotherapy improves the outlook for patients older than 1 year with Pediatric Oncology Group stage C neuroblastoma. J Clin Oncol 9:789-795 Cheung NK, Kushner BH, La Quaglia MP et al. (1997) Survival from non-stage 4 neuroblastoma without cytotoxic therapy: an analysis of clinical and biological markers. Eur J Cancer 33:2117-2120 De Bernardi B, Pianca C, Boni L et al. (1992) Disseminated neuroblastoma (stage IV and IV-S) in the first year of life. Outcome related to age and stage. Italian Cooperative Group on Neuroblastoma. Cancer 70:1625-1633 DuBois SG, Kalika Y, Lukens JN et al. (1999) Metastatic sites in stage IV and IVS neuroblastoma correlate with age, tumor biology, and survival. J Pediatr Hematol Oncol 21:181-189

Evans AE, Baum E, Chard R (1981) Do infants with stage IV-S neuroblastoma need treatment? Arch Dis Child 56:271-274 Evans AE, Silber JH, Shpilsky A et al. (1996) Successful management of low-stage neuroblastoma without adjuvant therapies: a comparison of two decades, 1972 through 1981 and 1982 through 1992, in a single institution. J Clin Oncol 14:2504-2510

Garaventa A, Boni L, Lo Piccolo MS et al. (2002) Localized unresectable neuroblastoma: results of treatment based on clinical prognostic factors. Ann Oncol 13:956-964 George R, London WB, Maris JM et al. (2003) Age as a continuous variable in predicting outcome for neuroblastoma patients with metastatic disease: impact of tumor biological features. Proc Am Soc Clin Oncol 22:799 (abstract) Guglielmi M, De Bernardi B, Rizzo A et al. (1996) Resection of primary tumor at diagnosis in stage IV-S neuroblastoma: Does it affect the clinical course? J Clin Oncol 14:1537-1544 Haase GM,Wong KY, deLorimier AA et al. (1989) Improvement in survival after excision of primary tumor in stage III neuroblastoma. J Pediatr Surg 24:194-200 Hachitanda Y, Hata J (1996) Stage IVS neuroblastoma: a clinical, histological, and biological analysis of 45 cases. Hum Pathol 27:1135-1138 Hero B, Simon T, Horz S et al. (2000) Metastatic neuroblastoma in infancy: What does the pattern of metastases contribute to prognosis? Med Pediatr Oncol 35:683-687 Katzenstein HM, Bowman LC, Brodeur GM et al. (1998) Prognostic significance of age, MYCN oncogene amplification,tu-mor cell ploidy, and histology in 110 infants with stage D(S) neuroblastoma: the Pediatric Oncology Group experience - a Pediatric Oncology Group Study. J Clin Oncol 16:2007-2017 Maris JM, Matthay KK (1999) Molecular biology of neuroblas-

toma. J Clin Oncol 17:2226-2279 Martinez DA, King DR, Ginn-Pease ME et al. (1992) Resection of the primary tumor is appropriate for children with stage IV-S neuroblastoma: an analysis of 37 patients. J Pediatr Surg 27:1016-1020 Matthay KK, Sather HN, Seeger RC et al. (1989) Excellent outcome of stage II neuroblastoma is independent of residual disease and radiation therapy. J Clin Oncol 7:236-244 Matthay KK, Perez C, Seeger RC et al. (1998) Successful treatment of stage III neuroblastoma based on prospective biologic staging: a Children's Cancer Group Study. J Clin Oncol 16:1256-1264

Nickerson HJ, Matthay KK, Seeger RC et al. (2000) Favorable biology and outcome of stage IV-S neuroblastoma with supportive care or minimal therapy: a Children's Cancer Group study. J Clin Oncol 18:477-486 Paul SR, Tarbell NJ, Korf B et al. (1991) Stage IV neuroblastoma in infants. Long-term survival. Cancer 67:1493-1497 Rosen EM, Cassady JR, Frantz CN et al. (1985) Stage IV-N: a favorable subset of children with metastatic neuroblastoma. Med Pediatr Oncol 13:194-198

Rubie H, Michon J, Plantaz D et al. (1998) Unresectable localized neuroblastoma: improved survival after primary chemotherapy including carboplatin-etoposide. Neuroblas-toma Study Group of the Societe Francaise d'Oncologie Pediatrique (SFOP). Br J Cancer 77:2310-2317

Rubie H, Plantaz D, Coze C et al. (2001) Localised and unre-sectable neuroblastoma in infants: excellent outcome with primary chemotherapy. Neuroblastoma Study Group, Societe Francaise d'Oncologie Pediatrique. Med Pediatr Oncol

36:247-250

Sauvat F, Sarnacki S, Brisse H et al. (2002) Outcome of suprarenal localized masses diagnosed during the perinatal period: a retrospective multicenter study. Cancer 94:24742480

Schleiermacher G, Rubie H, Hartmann O et al. (2003) Treatment of stage 4 s neuroblastoma: report of 10 years' experience of the French Society of Paediatric Oncology (SFOP). Br J Cancer 89:470-476

Schmidt ML, Lukens JN, Seeger RC et al. (2000) Biologic factors determine prognosis in infants with stage IV neuroblas-toma: a prospective Children's Cancer Group Study. J Clin Oncol 18:1260-1268

Schmidt ML, Lal A, Seeger R et al. (2003) Favorable prognosis for patients ages 12-18 months with stage 4 MYCN-nonam-plified neuroblastoma. Proc Am Soc Clin Oncol 22:800 (abstract)

Strother D, Shuster JJ, McWilliams N et al. (1995) Results of pediatric oncology group protocol 8104 for infants with stages D and DS neuroblastoma. J Pediatr Hematol Oncol

17:254-259

Strother D, van Hoff J, Rao PV et al. (1997) Event-free survival of children with biologically favourable neuroblastoma based on the degree of initial tumour resection: results from the Pediatric Oncology Group. Eur J Cancer 33:21212125

Tsuchida Y,Yokoyama J,Kaneko M et al.(1992) Therapeutic significance of surgery in advanced neuroblastoma: a report from the study group of Japan. J Pediatr Surg 27:616-622

Van Noesel MM, Hahlen K, Hakvoort-Cammel FGAJ et al. (1997) Neuroblastoma 4S: a heterogeneous disease with variable risk factors and treatment strategies. Cancer 80:834-843

West DC, Shamberger RC, Macklis RM et al. (1993) Stage III neuroblastoma over 1 year of age at diagnosis: improved survival with intensive multimodality therapy including multiple alkylating agents. J Clin Oncol 11:84-90

10 Ways To Fight Off Cancer

10 Ways To Fight Off Cancer

Learning About 10 Ways Fight Off Cancer Can Have Amazing Benefits For Your Life The Best Tips On How To Keep This Killer At Bay Discovering that you or a loved one has cancer can be utterly terrifying. All the same, once you comprehend the causes of cancer and learn how to reverse those causes, you or your loved one may have more than a fighting chance of beating out cancer.

Get My Free Ebook


Post a comment